KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Change in Acquisitions & Divestments (2016 - 2026)

Thermo Fisher Scientific filings provide 10 years of Change in Acquisitions & Divestments readings, the most recent being $250.0 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 12400.0% to $250.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.3 billion, a 87.96% increase, with the full-year FY2025 number at $1.6 billion, down 11.58% from a year prior.
  • Change in Acquisitions & Divestments hit $250.0 million in Q1 2026 for Thermo Fisher Scientific, down from $1.3 billion in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.8 billion in Q4 2024 to a low of $2.0 million in Q1 2025.
  • Median Change in Acquisitions & Divestments over the past 3 years was $780.5 million (2025), compared with a mean of $831.0 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: fell 25.55% in 2025 and later skyrocketed 12400.0% in 2026.
  • Thermo Fisher Scientific's Change in Acquisitions & Divestments stood at $1.8 billion in 2024, then fell by 25.55% to $1.3 billion in 2025, then crashed by 80.93% to $250.0 million in 2026.
  • The last three reported values for Change in Acquisitions & Divestments were $250.0 million (Q1 2026), $1.3 billion (Q4 2025), and $2.0 million (Q1 2025) per Business Quant data.